Adult GlioblastomaPhase 1NCT04573140Papers
Autologous total tumor mRNA
RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)
Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma
What the film says
When glioblastoma grows back, surgeons can operate again, but cells remain in the cavity wall, and those regrow.
The idea: at the end of that second surgery, seed the cavity wall with a virus that turns tumor cells into their own chemotherapy factories.
It is a common-cold adenovirus, rebuilt to multiply only in cancer cells, carrying two extra genes. Each converts a harmless pill, an antifungal and an antiviral, into a drug that kills dividing cells where the virus is. Radiation follows; both drugs make tumor cells more sensitive to it.
Henry Ford Health in Detroit tested this virus in prostate cancer for years. This trial, with Tobias Walbert, brings it to the brain, asking what dose is safe. Public record; not medical advice.
Sources behind this film
Repeat surgery; residual cells in the cavity wall regrow; Replication-competent adenovirus with two suicide genes: yeast cytosine deaminase (5-fluorocytosine → 5-FU) and HSV thymidine kinase (valganciclovir → toxic nucleotide); Both prodrug systems sensitize tumor cells to radiation; radiosurgery follows; Tested for years in prostate cancer at Henry Ford (+1 more lines)
Freytag SO. Hum Gene Ther, 1998
Replication-competent adenovirus with two suicide genes: yeast cytosine deaminase (5-fluorocytosine → 5-FU) and HSV thymidine kinase (valganciclovir → toxic nucleotide); Both prodrug systems sensitize tumor cells to radiation; radiosurgery follows
Freytag SO. Mol Ther, 2007
Tested for years in prostate cancer at Henry Ford
Freytag SO. Int J Radiat Oncol Biol Phys, 2014
Tested for years in prostate cancer at Henry Ford
The drug
Ad5-yCD/mutTKSR39rep-ADP adenovirus will be injected intratumoral
Detailed study description: Patients with recurrent glioblastoma (GBM) or progressive high grade astrocytoma who are scheduled to undergo repeat surgery are eligible. After the removal of as much tumor tissue as possible, a modified oncolytic adenovirus is injected into the wall of the resection cavity and any residual tumor tissue. The goal of this study is to determine the maximum tolerated dose (MTD) of the injected adenovirus.
This treatment is combined with a combination of oral 5-fluorocytosine (5-FC) and valganciclovir (vGCV) prodrug therapy. Following the surgery, patients will be treated with fractionated radiosurgery (fSRS). Patients will be monitored for 30 days before they start on next line anti-cancer therapy.
The study
The primary goal of this Phase I study is to determine the maximum tolerated dose of oncolytic adenovirus mediated double suicide-gene therapy in combination with fractionated stereotactic radiosurgery in patients with recurrent high-grade astrocytoma undergoing resection.
Eligibility
Inclusion criteria as written on the registry, trimmed. The full list, with exclusions, is on the live record.
For you, or someone you love
A complex diagnosis brings new questions every week, in a trial and out of one. Triangle keeps your whole medical file together, reads it with you in plain language, and helps you and your family decide what to ask next.
Then $9 a month. Cancel anytime.
Requested from your hospitals and clinics through the national networks. Add scans, pathology and anything on paper.
Reports explained as they come in, with lab values you can follow before treatment, during a trial and after.
Ask about your own file, and walk in with questions for your oncologist or the trial team.
Share one profile with the family helping you, and with your doctors.
Members also get a deeper analysis of their records and any sequencing data, including clinical trials that may fit, reviewed by a licensed physician before they receive it.
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.